BRCA 16+ PREVENTION OF HEREDITARY GYNECOLOGICAL CANCER DESCRIPTION: The BRCA test + 16 genes is an analysis of the patient's DNA by next generation sequencing – NGS (Next generation sequencing) to detect point mutations and small insertions/deletions in 18 genes (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, (For example, in the case of patients with cervical cancer). Additionally, the MLPA technique is performed (Múltiple Lipe Probe Amplification) of BRCA1 genes, BRCA2 and EPCAM for the detection of large deletions and duplications.